IP Library Granted Patent US 8,597,570
Granted Patent B2
US 8,597,570 · App. 13/127,247 · Granted Dec 3, 2013

Measurement device, insulin infusion device, measurement method, method for controlling insulin infusion device, and program

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,597,570
App. No.
13/127,247
Granted
Dec 3, 2013
Kind
B2
Abstract

Provided are a measurement device by which the blood-sugar level or the like associated with the living activity of a diabetic patient can be measured easily and precisely and the measured valued associated with the living activity can be clinically applied easily, and an insulin infusion device, a measurement method, a method for controlling an insulin fusion device, and a program. A blood-sugar level measurement device ( 100 ) is provided with a blood-sugar level sensor ( 200 ) and an acceleration sensor ( 112 ) for measuring movement information associated with human body activity, wherein a CPU ( 110 controls, on the basis of the measured movement information, whether or not the measurement operation of a blood-sugar measurement circuit ( 113 ) can be executed. The CPU ( 110 ) further associates and records in a recording unit ( 111 ) the measured blood-sugar level and the movement information measured by the acceleration sensor ( 112 ), and displays the associated blood-sugar level and movement information on a display unit ( 102 ). The CPU ( 110 ) further combines the blood-sugar level measured by the blood-sugar level sensor ( 200 ) and the data detected by the acceleration sensor ( 112 ) and executes each mode processing.

Claims (19)

1. A measurement device comprising:

a biosensor which includes a reagent surface on which a reagent is placed, the reagent selectively responding to a specific analyte in a biological fluid to detect the presence or concentration of the analyte in the biological fluid;

an analyte measurer that measures a characteristic amount of the analyte with a biosensor;

a motion measurer that measures the tilt angle or rotation angle of the reagent surface from a neutral position thereof, or vibration applied to the reagent surface, to output a measured value as motion information of living activity;

a recorder that records therein the characteristic amount of the analyte and the motion information; and

a controller that is programmed to perform a measurement operation and to allow the recorder to record therein the characteristic amount when the measured value as motion information of living activity is within a predetermined value range.

2. The measurement device according to claim 1 , wherein, when the measured value is within the predetermined value range, the controller controls the recorder to record therein the motion information.

3. The measurement device according to claim 1 , wherein,

when the tilt angle is within ±30%, the controller controls the analyte measurement section to perform a measurement operation.

4. The measurement device according to claim 1 , wherein, when the measured value is outside of the predetermined value range, the controller controls a notifier to notify a user to that effect.

5. The measurement device according to claim 1 , wherein the biosensor is an electrochemical sensor which includes a blood storage provided at an edge or substantially center of the reagent surface, a supply channel connected at one end to the storage and at the other end to an air vent, and an electrode for detecting blood's characteristic which is provided on one surface of the supply channel, and

wherein the motion measurer is spaced apart by a predetermined distance from a line connecting the storage and the electrode.

6. The measurement device according to claim 1 , wherein the biosensor is a blood glucose sensor for measuring blood glucose level.

7. The measurement device according to claim 5 , wherein the electrochemical sensor includes a blood glucose sensor for measuring blood glucose level, a lactic acid sensor for measuring lactic acid level, or cholesterol sensor for measuring cholesterol level.

8. The measurement device according to claim 1 , further comprising a housing for housing therein at least one of the analyte measurer, the motion measurer, the recorder and the controller, wherein the bio sensor is detachably connected to the housing.

9. The measurement device according to claim 1 , further comprising:

a housing for housing therein at least one of the analyte measurer, the motion measurer, the recorder and the controller; and

a damage monitor that determines the amount of damage to the housing based on the motion information and records in the recorder the damage amount and the number of times the housing has been damaged.

10. The measurement device according to claim 1 , wherein the motion measurer comprises an acceleration sensor.

Assignments (4)
CHANGE OF NAME Recorded May 18, 2018
From: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
To: PHC HOLDINGS CORPORATION
Reel/Frame 046198/0410 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2015
From: PANASONIC HEALTHCARE CO., LTD.
To: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
Reel/Frame 035210/0403 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2014
From: PANASONIC CORPORATION
To: PANASONIC HEALTHCARE CO., LTD.
Reel/Frame 032360/0795 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2011
From: TERASHIMA, NORIYOSHI; NADAOKA, MASATAKA
To: PANASONIC CORPORATION
Reel/Frame 026610/0501 →